Cancer BiologybioRxivPreprint
Bifidobacterium pseudocatenulatum capsular exopolysaccharide enhances systemic anti-tumour immunity in pre-clinical breast cancer
Christopher A. Price, Alicia D. Nicklin, Magdalena Kujawska…·Stephen David Robinson
This study shows that Bifidobacterium pseudocatenulatum 210 EPS enhances anti-tumour immunity and improves cancer therapy responses in pre-clinical models.
1 citation